学龄前喘息儿童急性期特异性基因模块与维生素D及哮喘用药相关
研究对6月龄至3岁急性喘息患儿(n=107)及健康对照(n=66)进行白细胞转录组分析,随访至7岁。发现急性喘息特异性基因模块与婴儿期维生素D水平及7岁时哮喘用药和FEV1%/FVC相关,基于基因表达可预测7岁时白三烯受体拮抗剂用药(AUC 0.815,95%CI 0.668-0.962)。
要点
- 急性喘息患儿存在固有免疫反应基因显著富集。
- 急性喘息特异性基因模块与婴儿期维生素D水平相关(p<0.005)。
- 该基因模块与7岁时哮喘用药及FEV1%/FVC相关(p<0.005)。
核心结论
- 学龄前喘息儿童血液基因表达谱可预测学龄期哮喘症状,可作为生物标志物。
- 急性喘息特异性基因模块提示早期分子表型结合临床信息有助于区分喘息自愈与发展为慢性哮喘的儿童。
研究设计与样本
- 分析6月龄至3岁学龄前儿童急性喘息时(n=107)及2-3个月后复诊时的白细胞转录组,并与年龄匹配健康对照(n=66)比较。
- 采用RNA测序结合GlobinLock技术,病例临床随访至7岁。
- 应用差异表达检验、加权相关网络分析和逻辑回归,评估与76项临床特征的关联。
主要发现
- 喘息儿童中固有免疫反应相关基因显著富集。
- 鉴定出独特的急性喘息特异性基因模块,与婴儿期维生素D水平相关(p<0.005)。
- 该基因模块与7岁时哮喘用药和FEV1%/FVC比值相关(p<0.005)。
- 建立预测7岁时白三烯受体拮抗剂用药的模型,曲线下面积0.815(95%CI 0.668-0.962)。
临床怎么用
- 早期喘息发作时进行血液基因表达检测可能辅助识别将发展为慢性哮喘的儿童。
- 结合临床信息与分子表型可帮助判断喘息儿童预后。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Airway obstruction and wheezing in preschool children with recurrent viral infections are a major clinical problem, and are recognised as a risk factor for the development of chronic asthma. We aimed to analyse whether gene expression profiling provides evidence for pathways that delineate distinct groups of children with wheeze, and in combination with clinical information could contribute to diagnosis and prognosis of disease development. METHODS: We analysed leukocyte transcriptomes from preschool children (6 months-3 years) at acute wheeze (n=107), and at a revisit 2-3 months later, comparing them to age-matched healthy controls (n=66). RNA-sequencing applying GlobinLock was used. The cases were followed clinically until age 7 years. Differential expression tests, weighted correlation network analysis and logistic regression were applied and correlations to 76 clinical traits evaluated. FINDINGS: Significant enrichment of genes involved in the innate immune responses was observed in children with wheeze. We identified a unique acute wheeze-specific gene-module, which was associated with vitamin D levels (p<0.005) in infancy, and asthma medication and FEV1%/FVC (forced expiratory volume in 1 s/forced vital capacity) ratio several years later, at age 7 years (p<0.005). A model that predicts leukotriene receptor antagonist medication at 7 years of age with high accuracy was developed (area under the curve 0.815, 95% CI 0.668-0.962). INTERPRETATION: Gene expression profiles in blood from preschool wheezers predict asthma symptoms at school age, and therefore serve as biomarkers. The acute wheeze-specific gene module suggests that molecular phenotyping in combination with clinical information already at an early episode of wheeze may help to distinguish children who will outgrow their wheeze from those who will develop chronic asthma.
引用
- Katayama S, Stenberg Hammar K, Krjutškov K, et al. Acute wheeze-specific gene module shows correlation with vitamin D and asthma medication. Eur Respir J. 2020. PMID: 31619476. doi:10.1183/13993003.01330-2019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。